RESUMO
Placenta accreta spectrum encompasses cases where the placenta is morbidly adherent to the myometrium. Placenta percreta, the most severe form of placenta accreta spectrum (grade 3E), occurs when the placenta invades through the myometrium and possibly into surrounding structures next to the uterine corpus. Maternal morbidity of placenta percreta is high, including severe maternal morbidity in 82.1% and mortality in 1.4% in the recent nationwide U.S. statistics. Although cesarean hysterectomy is commonly performed for patients with placenta accreta spectrum, conservative management is becoming more popular because of reduced morbidity in select cases. Treatment of grade 3E disease involving the urinary bladder, uterine cervix, or parametria is surgically complicated due to the location of the invasive placenta deep in the maternal pelvis. Cesarean hysterectomy in this setting has the potential for catastrophic hemorrhage and significant damage to surrounding organs. We propose a step-by-step schema to evaluate cases of grade 3E disease and determine whether immediate hysterectomy or conservative management, including planned delayed hysterectomy, is the most appropriate treatment option. The approach includes evaluation in the antenatal period with ultrasound and magnetic resonance imaging to determine suspicion for placenta previa percreta with surrounding organ involvement, planned cesarean delivery with a multidisciplinary team including experienced pelvic surgeons such as a gynecologic oncologist, intra-operative assessment including gross surgical field exposure and examination, cystoscopy, and consideration of careful intra-operative transvaginal ultrasound to determine the extent of placental invasion into surrounding organs. This evaluation helps decide the safety of primary cesarean hysterectomy. If safely resectable, additional considerations include intra-operative use of uterine artery embolization combined with tranexamic acid injection in cases at high risk for pelvic hemorrhage and ureteral stent placement. Availability of resuscitative endovascular balloon occlusion of the aorta is ideal. If safe resection is concerned, conservative management including planned delayed hysterectomy at around 4 weeks from cesarean delivery in stable patients is recommended.
Assuntos
Placenta Acreta , Placenta Prévia , Feminino , Gravidez , Humanos , Placenta Acreta/terapia , Placenta Acreta/patologia , Placenta , Placenta Prévia/patologia , Placenta Prévia/cirurgia , Miométrio/patologia , Cesárea , Histerectomia/métodos , Estudos RetrospectivosAssuntos
Procedimentos Endovasculares/normas , Radiografia Intervencionista/normas , Radiologia Intervencionista/normas , Ferimentos e Lesões/terapia , Algoritmos , Consenso , Procedimentos Clínicos/normas , Procedimentos Endovasculares/efeitos adversos , Procedimentos Endovasculares/mortalidade , Humanos , Radiografia Intervencionista/efeitos adversos , Radiografia Intervencionista/mortalidade , Resultado do Tratamento , Ferimentos e Lesões/diagnóstico , Ferimentos e Lesões/mortalidadeAssuntos
Anticoagulantes/administração & dosagem , Coagulação Sanguínea/efeitos dos fármacos , Cateterismo Periférico , Fibrinolíticos/administração & dosagem , Inibidores da Agregação Plaquetária/administração & dosagem , Radiografia Intervencionista , Trombose/prevenção & controle , Algoritmos , Anticoagulantes/efeitos adversos , Cateterismo Periférico/efeitos adversos , Comorbidade , Consenso , Técnicas de Apoio para a Decisão , Técnica Delphi , Interações Medicamentosas , Fibrinolíticos/efeitos adversos , Hemorragia/induzido quimicamente , Humanos , Inibidores da Agregação Plaquetária/efeitos adversos , Punções , Radiografia Intervencionista/efeitos adversos , Medição de Risco , Fatores de Risco , Trombose/sangue , Trombose/etiologia , Resultado do TratamentoAssuntos
Anticoagulantes/administração & dosagem , Coagulação Sanguínea/efeitos dos fármacos , Cateterismo Periférico , Fibrinolíticos/administração & dosagem , Inibidores da Agregação Plaquetária/administração & dosagem , Radiografia Intervencionista , Trombose/prevenção & controle , Anticoagulantes/efeitos adversos , Cateterismo Periférico/efeitos adversos , Comorbidade , Consenso , Técnica Delphi , Interações Medicamentosas , Fibrinolíticos/efeitos adversos , Hemorragia/induzido quimicamente , Humanos , Inibidores da Agregação Plaquetária/efeitos adversos , Punções , Radiografia Intervencionista/efeitos adversos , Medição de Risco , Fatores de Risco , Trombose/sangue , Trombose/etiologia , Resultado do TratamentoRESUMO
We report a case of a frozen elephant trunk arch repair, where the stent graft was unintentionally placed into the false lumen. Postoperative imaging demonstrated an enlarged false lumen with no thoracic aorta fenestrations that could be traversed to place another thoracic endovascular aortic repair endograft into the true lumen. An atraumatic radiofrequency wire (PowerWire, Baylis Medical, Montreal, Quebec, Canada) was used to create a new septal fenestration, enabling thoracic endovascular aortic repair endograft extension into the thoracic true lumen. This novel use of a radiofrequency wire can enable safe and controlled endovascular septal fenestration even in chronic dissections to redirect flow into the true lumen.
RESUMO
Treating patients with shock is not uncommon in an interventional radiologist's practice. Responding quickly to a patient's unexpected decompensation or feeling comfortable treating patients who have already developed shock requires a working knowledge of fluid resuscitation and sympathomimetic drugs used for blood pressure support. This article reviews medications commonly used for patients in shock and basic principles of initial fluid management.
Assuntos
Choque/tratamento farmacológico , Simpatomiméticos/uso terapêutico , HumanosAssuntos
Pancreatectomia , Fístula Pancreática , Complicações Pós-Operatórias , Implantação de Prótese , Deiscência da Ferida Operatória , Ferimentos Perfurantes/complicações , Colangiopancreatografia Retrógrada Endoscópica/métodos , Humanos , Laparotomia/métodos , Masculino , Pessoa de Meia-Idade , Pâncreas/lesões , Pancreatectomia/efeitos adversos , Pancreatectomia/métodos , Fístula Pancreática/diagnóstico , Fístula Pancreática/etiologia , Fístula Pancreática/fisiopatologia , Fístula Pancreática/terapia , Peritonite/etiologia , Peritonite/cirurgia , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/fisiopatologia , Complicações Pós-Operatórias/cirurgia , Implantação de Prótese/instrumentação , Implantação de Prótese/métodos , Baço/lesões , Esplenectomia/métodos , Stents , Deiscência da Ferida Operatória/etiologia , Deiscência da Ferida Operatória/terapia , Resultado do TratamentoRESUMO
PURPOSE: To report the initial clinical experience with the use of n-butyl cyanoacrylate (NBCA) for embolization of acute arterial hemorrhage from varied etiologies and at varied anatomic sites. MATERIALS AND METHODS: Sixteen patients who demonstrated active extravasation of contrast material and/or arterial abnormality underwent NBCA embolization. Sites of embolization included the gastrointestinal tract, kidney, liver, uterus, adrenal gland, extremity, and chest wall. Standard coil or particulate embolization had previously failed in 10 patients. NBCA was used as the initial embolic agent in the remaining six patients. After treatment, serial hematocrit levels, transfusion requirements, and clinical signs and symptoms were monitored for stabilization. Patients were evaluated for signs and symptoms of end-organ damage. RESULTS: NBCA embolization was successful in 12 of 16 patients (75%), who exhibited complete cessation of bleeding. In four patients (25%), NBCA embolization was of no benefit. Embolization failed in two of 16 patients (12.5%), who showed evidence of recurrent bleeding after use of NBCA. The remaining two patients (12.5%) died within 24 hours of the procedure. None of the 16 patients developed clinical signs of end-organ damage or iatrogenic ischemia attributable to NBCA. CONCLUSIONS: In this initial limited series, NBCA embolization was shown to be a feasible and effective method to control acute arterial hemorrhage. NBCA embolization was able to stop arterial bleeding even when previous coil or particulate embolization had failed.